Nachrichten zur Moderna Inc. Aktie

Stock Market Today: Dow, S&P 500, Nasdaq Set to Open Up; Tesla, Nvidia, Datadog, Marvell, Moderna, More Movers

Dow, S&P 500, and Nasdaq futures are rising in premarket trading as the stock market digests the latest labor market…

Earnings live: Moderna stock pops amid cost-cutting efforts, Snap stock soars, Duolingo plunges

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during…

Moderna Q3 Earnings Beat, Stock Up on Revised 25 Spending Plans

MRNA posts narrower-than-expected Q3 loss and lifts liquidity outlook for 2025, as cost cuts and revised spending plans boost investor…

Moderna trims top end of full-year forecast on weak COVID vaccine sales

…

Moderna: Saisonal stark dank Impfstoffnachfrage im November

Moderna ist ein US-Biotechnologieunternehmen mit Sitz in Cambridge, Massachusetts, das auf die Entwicklung von Medikamenten auf Basis der mRNA-Technologie spezialisiert…

Why Moderna (MRNA) Stock Is Falling Today

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing concerns about its financial performance and…

Moderna: Focus On Cancer Vaccines, Not Buyout

…

Moderna stock soars after report of potential buyout talks By Investing.com

Moderna stock soars after report of potential buyout talks…

Moderna (MRNA) Outperforms Broader Market: What You Need to Know

Moderna (MRNA) reached $26.74 at the closing of the latest trading day, reflecting a +1.87% change compared to its last…

Lancaster Opens $7 Million Position in 10x Genomics (TXG)

Key PointsLancaster Investment Management bought over 620,000 shares in 10x Genomics (TXG) worth around $7.27 million.10x Genomics, a new holding…

Moderna Aktie: Enttäuschende Nachricht

New York (www.aktiencheck.de) - Moderna-Aktienanalyse der Citigroup:Citigroup habe das Kursziel für die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9,…

Tesla, IBM and Moderna fall premarket; American Airlines rises By Investing.com

Tesla, IBM and Moderna fall premarket; American Airlines rises…

Stocks making the biggest moves after hours: IBM, Tesla, Moderna and more

These are the stocks posting the largest moves in extended trading.…

Moderna Vs BioNTech: Whos Winning The Post-COVID Race

…

Moderna, Inc. (MRNA) Shareholder/Analyst Call Transcript

…

Why Moderna Might Be a One-Hit Wonder

Modernas sales have plummeted in recent years along with diminishing demand for COVID vaccines.…

Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing

In the closing of the recent trading day, Moderna (MRNA) stood at $27.92, denoting a +2.12% move from the preceding…

Moderna (MRNA) Beats Stock Market Upswing: What Investors Need to Know

Moderna (MRNA) concluded the recent trading session at $28.38, signifying a +2.83% move from its prior days close.…

Could MRNAs Upcoming Product Launches Reduce COVID Sales Dependency?

Moderna plans up to 10 product launches over four years, aiming to cut reliance on fading COVID-19 vaccine sales.…

Moderna (MRNA) Dips More Than Broader Market: What You Should Know

In the closing of the recent trading day, Moderna (MRNA) stood at $24.61, denoting a -4.91% move from the preceding…

Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know

In the most recent trading session, Moderna (MRNA) closed at $25.51, indicating a +2.03% shift from the previous trading day.…

Lipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034

Growth in the Lipid Nanoparticles (LNPs) market is driven by increasing demand for mRNA-based therapeutics and advances in delivery systems.…

Die beste Wette auf mRNA – Wer im Wettlauf Biontech vs. Moderna vorn liegt

Biontech und Moderna erzielten Milliardengewinne mit Impfstoffen. Inzwischen ist das Boomgeschäft eingebrochen – und die Strategien driften auseinander. Während Moderna…

Heres What Key Metrics Tell Us About Moderna (MRNA) Q2 Earnings

Although the revenue and EPS for Moderna (MRNA) give a sense of how its business performed in the quarter ended…

Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.

Moderna also lost less than Wall Street analysts were expecting for the second quarter and posted revenue that topped estimates.…

Market movers: Coinbase, Reddit, Moderna...

…

Earnings call transcript: Moderna Q2 2025 beats forecasts, stock dips By Investing.com

Earnings call transcript: Moderna Q2 2025 beats forecasts, stock dips…

Moderna quarterly sales beat Street estimates on COVID booster sales, cost cuts

Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by robust Spring COVID booster…

Moderna slashes full-year sales outlook, reduces headcount

Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares fell almost 9% in early trade as the pharmaceutical giant lowered its full-year guidance and…

Nach Corona kommt die Krise: Moderna streicht jede zehnte Stelle

Während der Corona-Pandemie benötigt der Pharmakonzern Moderna viele zusätzliche Angestellte, um mit der Impfstoffentwicklung und -produktion nachzukommen. Jetzt ebbt die…

Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow

In a memo to employees, Moderna CEO Stephane Bancel said the company expects to have fewer than 5,000 workers by…

Pandemic darlings Moderna, BioNTech are now on two different paths

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find themselves on different…

Moderna to cut 10% of global workforce, CEO Bancel says By Investing.com

Moderna to cut 10% of global workforce, CEO Bancel says…

Moderna: Kooperation mit IBM soll mRNA-Entwicklung beschleunigen

Moderna ist ein US-amerikanisches Biotechnologieunternehmen mit Sitz in Cambridge, Massachusetts, das sich auf die Entwicklung von mRNA-basierten Therapien und Impfstoffen…

Moderna (MRNA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

Moderna (MRNA) Stock Slides as Market Rises: Facts to Know Before You Trade

In the latest trading session, Moderna (MRNA) closed at $34.01, marking a -1.9% move from the previous day.…

InnovationRx: Sarepta Blinks In Showdown With FDA

In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at…

Moderna Aktie: Kursziel runter, Chancen begrenzt? BofA warnt!

Charlotte (www.aktiencheck.de) - Moderna-Aktienanalyse von BofA Securities: Die Analysten von BofA Securities stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN:…

Heres Why Moderna (MRNA) Fell More Than Broader Market

In the most recent trading session, Moderna (MRNA) closed at $31.25, indicating a -2.95% shift from the previous trading day.…

Will 45% Of Work At Moderna Be Completed By AI By 2030? Yes

Firms like Moderna that are rapidly adopting AI and will have a higher mix of AI software robots to humans…

Moderna: Ready For The Redemption Arc

…

Opinion: Its Time to Load Up on This Biotech Giant After Its 80% Crash

Key PointsThis stock used to be a highflyer but has struggled in recent years as demand waned for its flagship…

Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights

The latest trading day saw Moderna (MRNA) settling at $33.64, representing a -1.87% change from its previous close.…

MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients

Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months…

Moderna stock rating reiterated at Buy by Brookline Capital Markets By Investing.com

Moderna stock rating reiterated at Buy by Brookline Capital Markets…

2 Beaten-Down Stocks to Buy and Hold

Key PointsModerna has a deep pipeline of promising mRNA candidates that stand to boost business.Regeneron is looking at label expansions…

Where Will Moderna Be in 10 Years?

Key PointsAfter soaring in early pandemic days, Moderna has fallen into the doldrums. An explosive phase of growth may be…

Why Moderna Stock Was So Healthy This Week

Key PointsThe company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine.This might…

Moderna Aktie: Ein Silberstreif - Chartanalyse

Düsseldorf (www.aktiencheck.de) - Moderna-Chartanalyse von HSBC Trinkaus & Burkhardt: Die Analysten von HSBC Trinkaus & Burkhardt nehmen in einer aktuellen Aktienanalyse…

MRNA Stock Jumps on CDCs Revised RSV Vaccine Recommendations

Moderna rises as CDC expands RSV vaccine guidance to include high-risk adults aged 50-59, boosting mResvias reach.…